International clinical trials published have confirmed the hope that cheap, widely available steroid drugs can help seriously ill patients survive COVID-19.
Based on the new evidence, WHO has issued new treatment guidance.
It has strongly recommended steroids to treat severely and critically ill patients, but not to those with mild disease.